Savara Pharmaceuticals is a U.S.-based emerging pharmaceutical development company with an affiliate site in Denmark. The company is focused on advancing a pipeline of novel inhalation therapies for the treatment of patients with rare pulmonary conditions.
Savara, Inc. to Host Earnings Call Wed, 08 Nov 2017 20:30:00 +0000 NEW YORK, NY / ACCESSWIRE / November 8, 2017 / Savara, Inc. (NASDAQ: SVRA ) will be discussing their earnings results in their Q3 Earnings Call to be held on November 8, 2017 at 5:30 PM Eastern Time. To ...
Savara Announces Pricing of Public Offering of Common Stock Wed, 25 Oct 2017 13:34:42 +0000 Savara, Inc. , an orphan lung disease company, today announced the pricing of an underwritten public offering of 5,250,000 shares of its common stock at a price to the public of $7.85 per share. As a component ...
Savara Announces Proposed Public Offering of Common Stock Tue, 24 Oct 2017 20:05:55 +0000 Savara, Inc. , an orphan lung disease company, today announced that it intends to offer and sell, subject to market conditions, shares of its common stock in an underwritten public offering. In addition, ...
Savara Announces Uplisting to the Nasdaq Global Select Market(R) Thu, 19 Oct 2017 12:00:00 +0000 Savara, Inc. , a clinical-stage specialty pharmaceutical company focused on the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases, ...
Savara Announces Start of Pivotal Phase III AVAIL Study of AeroVanc Tue, 26 Sep 2017 12:00:00 +0000 Savara, Inc. , a clinical-stage specialty pharmaceutical company focused on the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases, ...
*Winners defined as our Top Picks that increased 20% or more within a 6-month period.
Red Letters imply that that particular criteria did not meet minimum requirements, e.g., a low GSA Rank would show it in red.
___ Red Line On Graph Shows a Trailing Stop Loss Based on Support and Resistance Levels. See how it works.
___ Blue Line On Graph Shows the 10-Week Moving Average.
___ Magenta Line On Graph Shows the 40-Week Moving Average.
Disclaimer The stock selections in our stock investing and stock trading database are not stock recommendations, but simply represent applications of a stock investing process. All materials, including our Top Stock Picks, are provided for information purposes only and should not be used or construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security. Growth Stock Analytics, LLC is not responsible for gains/losses that may result in investing or trading in these securities. All information is believed to be obtained from reliable sources, but there is no guarantee that the information supplied is accurate, complete or timely. There is no guarantee or warranty with regard to the results obtained from its use. There is no guarantee of suitability or potential value of any particular investment or information source. You acknowledge that your requests for this information are unsolicited and shall neither constitute nor be considered investment advice. Past investing performance is not an indication of future performance results. Investing and trading in stocks is risky. Investors are encouraged to consult a registered stock broker or investment adviser before making any investing decisions. The interpretations and opinions expressed herein are solely those of Growth Stock Analytics, LLC, and not of any other individual or organization.